Search by Drug Name or NDC
NDC 61269-0410-20 ETOPOPHOS 100 mg/1 Details
ETOPOPHOS 100 mg/1
ETOPOPHOS is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by H2-Pharma, LLC. The primary component is ETOPOSIDE PHOSPHATE.
MedlinePlus Drug Summary
Etoposide injection is used in combination with other medications to treat cancer of the testicles that has not improved or that has worsened after treatment with other medications or radiation therapy. Etoposide injection is also used in combination with other medications to treat a certain type of lung cancer (small cell lung cancer; SCLC). Etoposide is in a class of medications known as podophyllotoxin derivatives. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 61269-0410-20Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Etoposide Injection
Product Information
| NDC | 61269-0410 |
|---|---|
| Product ID | 61269-410_839c17f5-4739-4ace-93b0-c6fd1a5710d2 |
| Associated GPIs | 21500010602120 |
| GCN Sequence Number | 027350 |
| GCN Sequence Number Description | etoposide phosphate VIAL 100 MG INTRAVEN |
| HIC3 | V1F |
| HIC3 Description | ANTINEOPLASTICS,MISCELLANEOUS |
| GCN | 07552 |
| HICL Sequence Number | 011549 |
| HICL Sequence Number Description | ETOPOSIDE PHOSPHATE |
| Brand/Generic | Brand |
| Proprietary Name | ETOPOPHOS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | etoposide phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | ETOPOSIDE PHOSPHATE |
| Labeler Name | H2-Pharma, LLC |
| Pharmaceutical Class | Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020457 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61269-0410-20 (61269041020)
| NDC Package Code | 61269-410-20 |
|---|---|
| Billing NDC | 61269041020 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (61269-410-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2009-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |